Tech Company Financing Transactions
Centauri Therapeutics Funding Round
AMR Action Fund and private investors joined a $8.1 million Series A funding round for Centauri Therapeutics. The round was announced on 2/24/2026.
Transaction Overview
Company Name
Announced On
2/24/2026
Transaction Type
Venture Equity
Amount
$8,100,000
Round
Series A
Investors
AMR Action Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the completion of Phase I clinical studies for CTX-187, its lead clinical candidate in the ABX-01 programme, and expand the scope of additional research activities in preparation for Phase II.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Discovery Park
Kent, CT13 9ND
United Kingdom
Kent, CT13 9ND
United Kingdom
Phone
Website
Email Address
Overview
Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Michael Westby
Co-Founder
Stuart Lawson
Browse more venture capital transactions:
Prev: 2/24/2026: Voiceline venture capital transaction
Next: 2/24/2026: Thema venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions on this site are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs